IncyteCARES Copay/Coinsurance Program - Jakafi
Incyte Corporation · Jakafi
Patient pays: as little as $0 per month
commercial insurance
Patient assistance
Tell us your insurance and household details. We’ll show you every Jakafi assistance program you may qualify for - the real manufacturer and foundation programs, not a discount card - with sources and a direct link to apply. About a minute, no login.
Jakafi help that still works on Medicare or Medicaid - the programs copay cards leave out.
Jakafi (ruxolitinib) is a jak1/jak2 inhibitor (oral oncology/hematology) made by Incyte Corporation. It is commonly prescribed for: Myelofibrosis (intermediate/high risk), Polycythemia vera (resistant or intolerant to hydroxyurea), Acute graft-versus-host disease (steroid-refractory), Chronic graft-versus-host disease. Without financial assistance, Jakafi typically costs around $16,000 per month.
Tell us five things. We’ll do the rest.
Reference
This is the full list before we filter by your situation. Use the calculator above to see only the ones you may qualify for.
Incyte Corporation · Jakafi
Patient pays: as little as $0 per month
commercial insurance
Incyte Corporation · Jakafi
uninsured · underinsured
Common questions